ETF comparison
IDNA vs IXJ overlap
Compare IDNA ETF and IXJ ETF by shared holdings, expense ratio, issuer, category, and tracked overlap.
Tracked overlap11.16%
11 shared holdings
IDNA expense0.00%
Unknown
IXJ expense0.00%
Unknown
Data date2026-05-01
2026-05-01
Shared top holdings
Overlap uses the smaller fund weight for each shared holding.
ROPROCHE PS PAR AG
VRTXVERTEX PHARMACEUTICALS INC
GSKGLAXOSMITHKLINE
SANSANOFI SA
REGNREGENERON PHARMACEUTICALS INC
4502TAKEDA PHARMACEUTICAL LTD
Interpretation
Should you own both IDNA and IXJ?
IDNA and IXJ share 11 tracked holdings with 11.16% overlap in the imported holdings set. High overlap can be fine when the funds serve a deliberate role, but it can also mean less diversification than the ticker count suggests.
Use the portfolio analyzer to test your actual allocations. Pairwise overlap does not account for how much of each ETF you own.